Abstract
Background: N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, also known as microsize MI. These events are now routinely detectable with modern troponin assays and are emerging as a large proportion of all MI. Here, we sought to compare the association of NT-proBNP with risk of incident typical MI and microsize MI in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
Methods: The REGARDS Study is a national cohort of 30,239 US community-dwelling black and white adults aged ≥ 45 years recruited from 2003 to 2007. Expert-adjudicated outcomes included incident typical MI (definite/probable MI with peak troponin ≥ 0.5 μg/L), incident microsize MI (definite/probable MI with peak troponin < 0.5 μg/L), and incident fatal CHD. Using a case-cohort design, we estimated the hazard ratio of the outcomes as a function of baseline NT-proBNP. Competing risk analyses tested whether the associations of NT-proBNP differed between the risk of incident microsize MI and incident typical MI as well as if the association of NT-proBNP differed between incident non-fatal microsize MI and incident non-fatal typical MI, while accounting for incident fatal coronary heart disease (CHD) as well as heart failure (HF).
Results: Over a median of 5 years of follow-up, there were 315 typical MI, 139 microsize MI, and 195 incident fatal CHD. NT-proBNP was independently and strongly associated with all CHD endpoints, with significantly greater risk observed for incident microsize MI, even after removing individuals with suspected HF prior to or coincident with their incident CHD event.
Conclusion: NT-proBNP is associated with all MIs, but is a more powerful risk factor for microsize than typical MI.
Document Type
Article
Publication Date
4-16-2018
Digital Object Identifier (DOI)
https://doi.org/10.1186/s12872-018-0806-4
Funding Information
This research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. Dr. Sterling is supported by grant number T32HS000066 from the Agency for Healthcare Research and Quality.
Related Content
The data analyzed during the current study belong to REGARDS and further inquiry can be made at http://www.regardsstudy.org.
Repository Citation
Sterling, Madeline R.; Durant, Raegan W.; Bryan, Joanna; Levitan, Emily B.; Brown, Todd M.; Khodneva, Yulia; Glasser, Stephen P.; Richman, Joshua S.; Howard, George; Cushman, Mary; and Safford, Monika M., "N-Terminal Pro-B-Type Natriuretic Peptide and Microsize Myocardial Infarction Risk in the Reasons for Geographic and Racial Differences in Stroke Study" (2018). Internal Medicine Faculty Publications. 140.
https://uknowledge.uky.edu/internalmedicine_facpub/140
Additional file 1: Figure S1, Table S1-S2.
Notes/Citation Information
Published in BMC Cardiovascular Disorders, v. 18, 66, p. 1-9.
© The Author(s). 2018
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.